We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
And without contracts, drift
tp 85p to buy back some
Yet no sign of contracts!
Yes, looks like the MMs are trying to pick up cheap shares before news.
Price dropping on zero volume again. Really needs news drip-fed to keep it going. Pilots to contracts please!
The EPR one never had anything to do with us. I suspect our one shows as unawarded because they extended to 30 June (so no need to ‘officially’ award yet). But I agree - frustrating.
OK, I found the Nov 23 tender. Still unawarded. Frustrating.
Https://bidstats.uk/tenders/2024/W14/819986488
EPR tender awarded, can't see the £1.6m diagnostics tender any more?
Bit of a flat week then! EOY NHS spend here same as last year?
Come on Tom, wake us up.
April 2nd, RNS this week? The board minutes suggested Feb 28th, I wonder what the holdup is?
Plus news from other pilots due.
Don't tell him that, he'll be offering another free carry trial.
Cut Tom's salary and put him on part time, roll him out for interviews for the next placing.
Employ a National sales Manager, set him a target to trundle around the NHS centres and SELL at breakeven cost the system on a 12 month introductory price, thereafter a rolling 12 month at cost plus margin deal.
If Yr sales manager can't sell any within 6 months stop trying with the NHS, lay off sales manager and focus on India and licensing to the USA.
Https://www.digitalhealth.net/2024/03/ransomware-group-releases-nhs-dumfries-and-galloway-patient-data/
get on the phone to them Tom
A number of larger trades this afternoon and after hours which all look like purchases. The price did tick up which reinforces this notion.
There is a lot of news due in the short term going by the comments in the recent investormeet.
Need an atomic RNS tomorrow.
The great thing with AIM BOD's is they can chat to each other and agree the options we're probably set too high.
Especially after issuing 5hit loads of shares for placings ...
Then they can agree they will lower their options...
I'm still invested here Dibs, just telling it like it is on AIM ;)
3.0p at options would equate to £6 now. Just over a year to make it happenTom. That would be some achievement but it's certainly doable.
They'll get India sorted by then.
India is being pilot scheme funded in charitable donations, they will then ask for central Government support / funding to cover the whole country.
Months away at the earliest, same as UK NHS.
Unless it can bring cash in via licensing bleepa to usa? I'd expect another £5m? Raise to keep all these trials running, unless Tom can man up and sell the proposition instead of giving it away.
Was reading about bids this morning, old favourite, great product, 5hit BOD, was obvious a while ago, come on Tom cup those balls in one hand and go sell some Bleepa!
Still some way to go if the Directors / employees want their grant of options given to them in 2022, but it only needs to peak at these prices. 1.20p is 240 in todays money and they have until may 2025. Hopefully they have a pipeline full of anouncements this year.
· One-third will vest if the share price reaches at least 1.20p, during the period commencing 31/05/2022 and ending 31/05/2025;
· One-third will vest if the share price reaches at least 1.86p during the period commencing 31/05/2023 and ending 31/05/2025; and
· One-third will vest if the share price reaches at least 3.0p during the period commencing 31/05/2024 and ending 31/05/2025.
Let's see if they can make it happen this year
Earl - you pick up some casp - its moving again.
Davey, I disagree with that I think the pumpers and dumpers can alert you to some good stocks you wouldn't otherwise know about, wait for them to leave then buy in on the retrace and wait.
Hilarious. These day traders or pump and dumpers over a course of a year pump maybe 100-150 stocks for a quick 5% or less. All the ones that go bust, get delisted, drop 90% are never mentioned again but any stock that does go on to double or more they are gloating what brilliant tipsters they are so they can ramp their latest stock on here. Discodog is another one for instant filter chaps
Pretomanid is used on drug resistant TB strains, sold by Viatris, now promoted into India via the Heal foundation and Bleepa and Carelocker.
https://en.wikipedia.org/wiki/Pretomanid
Europe https://www.ema.europa.eu/en/medicines/human/EPAR/dovprela-previously-pretomanid-fgk
U.S.A. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461242/
India https://www.viatris.com/en-in/lm/India ( https://www.mylan.in/en/news/press-releases/2020/mylan-secures-dcgi-approval-in-india-for-pretomanid-a-treatment-for-highly-drug-resistant-forms-of-tuberculosis )
According to the report, India accounted for the highest global TB burden, with 27% of the 10.6 million people diagnosed with the disease in 2022. The country is also home to 47% of people who developed multi-drug resistant infection which is unresponsive or resistant to at least two of the first line of anti-TB drugs the same year.
Bleepa get paid to test everyone as they have to have a carelocker file set up, Viatris get to sell the cure to those affected.
This is take off time.
#FDBK
WHY are Viatris paying for Heal and Bleepa to test all of Indias 1.4B people?
Pretomanid
Viatris has launched pretomanid, specifically approved for adults with MDR-TB. It’s only the third new anti-TB drug approved in the past half-century.
THEY OWN THE CURE!
I read the RNS and had a head scratch about a charity funding this with donations for the whole of India, had a google search.
Heal is a charity, it is run by a Pharmaceutical giant called Viatris, tied in with the Indian Government to eradicate TB by 2025.
To do this they need fast, snappy communications from medical people to the Indian population to tell them clear or infected, they have an obvious weakness in communications and this is the area that Bleepa and care locker fill.
Viatris filed this ...
FY 2023 results:
‣ Total Revenues $15.4B
‣ Adjusted EBITDA $5.1B
‣ Free Cash Flow $2.4B
https://investor.viatris.com/static-files/4ba5a0bf-5ae4-4425-a697-233a95c6c763
Dr Dhara Shah, Head of Medical Affairs, Viatris India, said, “TB eradication in India is at a crucial juncture. The government is spearheading the TB elimination program to end TB by 2025. Via the India Fights TB initiative, we will provide accurate information to patients,
revenue growth
‣ FY 2023 results:
‣ Total Revenues $15.4B
‣ Adjusted EBITDA $5.1B
‣ Free Cash Flow $2.4B
https://investor.viatris.com/financial-and-filings/quarterly-results
Feeling more relaxed now a "charity" is going to support Bleepa in India.
Why is it still under a tenner?
These traders are insufferable !
Think I'll stick with the absolutely certain multibagger, ta.